|Bid||0.6500 x 0|
|Ask||0.7500 x 0|
|Day's Range||0.6800 - 0.7500|
|52 Week Range||0.4300 - 0.9900|
|Beta (5Y Monthly)||0.65|
|PE Ratio (TTM)||12.59|
|Earnings Date||May 20, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results for the three month period ended March 31, 2022. Biorem's complete 2022 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2021. Biorem's complete fiscal 2021 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).